LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: From morphology to methylome: epigenetic studies of Müllerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma

    Lin, Lawrence H / Howitt, Brooke E / Kolin, David L

    The Journal of pathology

    2024  

    Abstract: Mesonephric adenocarcinomas (MAs) and mesonephric-like adenocarcinomas (MLAs) are rare, aggressive neoplasms that arise in the gynecologic tract and show overlapping morphologic, immunohistochemical, and molecular features. While MAs occur in the cervix ... ...

    Abstract Mesonephric adenocarcinomas (MAs) and mesonephric-like adenocarcinomas (MLAs) are rare, aggressive neoplasms that arise in the gynecologic tract and show overlapping morphologic, immunohistochemical, and molecular features. While MAs occur in the cervix and are thought to arise from mesonephric remnants, MLAs occur in the endometrium and ovary and are believed to originate from transdifferentiation of Müllerian lesions. Both MAs and MLAs show a variety of architectural patterns, exhibit frequent expression of GATA3 by immunohistochemistry, and harbor KRAS mutations. In a recent article published in The Journal of Pathology, Kommoss and colleagues used DNA methylation profiling to extend these similarities and showed that MLAs and MAs cluster together based on their epigenetic signatures and are epigenetically distinct from other Müllerian adenocarcinomas. They also showed that MLAs and MAs harbor a high number of global copy number alterations. This study provides evidence that MLAs more closely resemble MAs than Müllerian carcinomas on an epigenetic level. As a result, the authors argue that MLA should be renamed 'mesonephric-type adenocarcinoma.' Further research is needed to establish the relationship between these two entities, their etiology, and pathogenesis. © 2024 The Pathological Society of Great Britain and Ireland.
    Language English
    Publishing date 2024-04-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 3119-7
    ISSN 1096-9896 ; 0022-3417
    ISSN (online) 1096-9896
    ISSN 0022-3417
    DOI 10.1002/path.6285
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Role of High-Risk HPV Testing in Papanicolaou Tests With Atypical Glandular Cells With and Without Concurrent Squamous Cell Abnormalities.

    Lin, Lawrence H / Koloori, Maryam N / Brandler, Tamar C / Simsir, Aylin

    American journal of clinical pathology

    2022  Volume 158, Issue 5, Page(s) 626–631

    Abstract: Objectives: Data on Papanicolaou (Pap) tests with atypical glandular cells (AGCs) with concurrent squamous cell abnormalities (AGC + Sq) are limited. We evaluated histologic outcomes and the role of high-risk human papillomavirus (HR-HPV) testing in ... ...

    Abstract Objectives: Data on Papanicolaou (Pap) tests with atypical glandular cells (AGCs) with concurrent squamous cell abnormalities (AGC + Sq) are limited. We evaluated histologic outcomes and the role of high-risk human papillomavirus (HR-HPV) testing in this setting compared with AGCs without concurrent squamous cell abnormalities (AGC-alone).
    Methods: This study used a retrospective cohort of patients with Pap test diagnoses of AGC + Sq and AGC-alone between October 2013 and August 2021.
    Results: We included 287 Pap tests from 278 patients. The HR-HPV test was positive in 55% of AGC + Sq cases and 14% of AGC-alone cases (P < .0001). Most AGC + Sq cases displayed squamous lesions (41.5%) or were benign (41.5%) on histology, whereas AGC-alone cases were predominantly benign (72%) or extracervical neoplasms (18%). AGC + Sq cases showed higher rates of significant histologic lesions (P = .0001), which were associated with positive HR-HPV status (P = .0012). In AGC-alone cases, HR-HPV status was associated with significant histology only in patients 50 years of age or younger. In both groups, 20% or more of HR-HPV-negative patients harbored significant lesions.
    Conclusions: AGC + Sq represents a distinct group of patients. HR-HPV testing and patient age provide useful information in the evaluation of AGC, but triage based on HR-HPV testing is not recommended because of the potential for missing significant lesions.
    MeSH term(s) Female ; Humans ; Papanicolaou Test ; Cervical Intraepithelial Neoplasia/diagnosis ; Papillomavirus Infections/complications ; Papillomavirus Infections/diagnosis ; Papillomaviridae ; Retrospective Studies ; Uterine Cervical Neoplasms ; Vaginal Smears ; Epithelial Cells/pathology
    Language English
    Publishing date 2022-09-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1093/ajcp/aqac097
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Investigating the spectrum of dermatologic manifestations in COVID-19 infection in severely ill patients: A series of four cases.

    Occidental, Michael / Flaifel, Abdallah / Lin, Lawrence H / Guzzetta, Melissa / Thomas, Kristen / Jour, George

    Journal of cutaneous pathology

    2020  Volume 48, Issue 1, Page(s) 110–115

    Abstract: COVID-19, an infectious disease caused by the novel coronavirus, was initially identified in Wuhan, China, in December 2019. By March 2020, it was declared a pandemic by the World Health Organization. Although most findings have been reported in the ... ...

    Abstract COVID-19, an infectious disease caused by the novel coronavirus, was initially identified in Wuhan, China, in December 2019. By March 2020, it was declared a pandemic by the World Health Organization. Although most findings have been reported in the lungs, primarily due to catastrophic respiratory decline, other organs, including the skin, are affected. Recent reports have been published describing the clinical spectrum of COVID-19-related lesions. In addition, recent case series have described a subset of these lesions having underlying thrombotic microangiopathy with increased complement activation characterized by increased C4d deposition within the blood vessel walls. Herein, we describe a series of COVID-19-related cutaneous manifestations found at autopsy examination and their underlying histopathologic findings. Although the clinical manifestations seen in these lesions vary widely, the underlying etiology of thrombotic microangiopathy remains consistent and reproducible.
    MeSH term(s) COVID-19/complications ; Humans ; Male ; Middle Aged ; SARS-CoV-2 ; Skin Diseases, Viral/pathology ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-09-28
    Publishing country United States
    Document type Case Reports
    ZDB-ID 187078-6
    ISSN 1600-0560 ; 0303-6987
    ISSN (online) 1600-0560
    ISSN 0303-6987
    DOI 10.1111/cup.13867
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease.

    Barrett, Tessa J / Lee, Angela H / Xia, Yuhe / Lin, Lawrence H / Black, Margaret / Cotzia, Paolo / Hochman, Judith / Berger, Jeffrey S

    Circulation research

    2020  Volume 127, Issue 7, Page(s) 945–947

    MeSH term(s) Aged ; Biomarkers/blood ; CD40 Antigens/blood ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/complications ; Coronavirus Infections/mortality ; Coronavirus Infections/pathology ; Female ; Hemoglobins/analysis ; Humans ; Lymphocyte Count ; Male ; Mean Platelet Volume ; Middle Aged ; P-Selectin/blood ; Pandemics ; Platelet Count ; Pneumonia, Viral/blood ; Pneumonia, Viral/complications ; Pneumonia, Viral/mortality ; Pneumonia, Viral/pathology ; Thrombosis/blood ; Thrombosis/etiology ; Thromboxane B2/blood
    Chemical Substances Biomarkers ; CD40 Antigens ; Hemoglobins ; P-Selectin ; Thromboxane B2 (54397-85-2)
    Keywords covid19
    Language English
    Publishing date 2020-08-06
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.120.317803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Investigating the spectrum of dermatologic manifestations in COVID-19 infection in severely ill patients: A series of four cases

    Occidental, Michael / Flaifel, Abdallah / Lin, Lawrence H / Guzzetta, Melissa / Thomas, Kristen / Jour, George

    J. cutan. pathol

    Abstract: COVID-19, an infectious disease caused by the novel coronavirus, was initially identified in Wuhan, China, in December 2019. By March 2020, it was declared a pandemic by the World Health Organization. Although most findings have been reported in the ... ...

    Abstract COVID-19, an infectious disease caused by the novel coronavirus, was initially identified in Wuhan, China, in December 2019. By March 2020, it was declared a pandemic by the World Health Organization. Although most findings have been reported in the lungs, primarily due to catastrophic respiratory decline, other organs, including the skin, are affected. Recent reports have been published describing the clinical spectrum of COVID-19-related lesions. In addition, recent case series have described a subset of these lesions having underlying thrombotic microangiopathy with increased complement activation characterized by increased C4d deposition within the blood vessel walls. Herein, we describe a series of COVID-19-related cutaneous manifestations found at autopsy examination and their underlying histopathologic findings. Although the clinical manifestations seen in these lesions vary widely, the underlying etiology of thrombotic microangiopathy remains consistent and reproducible.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #748638
    Database COVID19

    Kategorien

  6. Article ; Online: Investigating the spectrum of dermatologic manifestations in COVID ‐19 infection in severely ill patients

    Occidental, Michael / Flaifel, Abdallah / Lin, Lawrence H. / Guzzetta, Melissa / Thomas, Kristen / Jour, George

    Journal of Cutaneous Pathology ; ISSN 0303-6987 1600-0560

    A series of four cases

    2020  

    Keywords Pathology and Forensic Medicine ; Histology ; Dermatology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1111/cup.13867
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia.

    St Laurent, Jessica D / Lin, Lawrence H / Owen, David M / Maestá, Izildinha / Castaneda, Arnold / Hasselblatt, Kathleen T / Goldstein, Donald P / Horowitz, Neil S / Berkowitz, Ross S / Elias, Kevin M

    Reproductive sciences (Thousand Oaks, Calif.)

    2021  Volume 28, Issue 11, Page(s) 3200–3211

    Abstract: To investigate if differences in imprinting at tropho-microRNA (miRNA) genomic clusters can distinguish between pre-gestational trophoblastic neoplasia cases (pre-GTN) and benign complete hydatidiform mole (CHM) cases at the time of initial uterine ... ...

    Abstract To investigate if differences in imprinting at tropho-microRNA (miRNA) genomic clusters can distinguish between pre-gestational trophoblastic neoplasia cases (pre-GTN) and benign complete hydatidiform mole (CHM) cases at the time of initial uterine evacuation. miRNA sequencing was performed on frozen tissue from 39 CHM cases including 9 GTN cases. DIO3, DLK1, RTL1, and MEG 3 mRNA levels were assessed by qRT-PCR. Protein abundance was assessed by Western blot for DIO3, DLK1, and RTL1. qRT-PCR and Western blot were performed for selenoproteins and markers of oxidative stress. Immunohistochemistry (IHC) was performed for DIO3 on an independent validation set of clinical samples (n = 42) and compared to normal placenta controls across gestational ages. Relative expression of the 14q32 miRNA cluster was lower in pre-GTN cases. There were no differences in protein abundance of DLK1 or RTL1. Notably, there was lower protein expression of DIO3 in pre-GTN cases (5-fold, p < 0.03). There were no differences in mRNA levels of DIO3, DLK1, RTL1 or MEG 3. mRNA levels were higher in all CHM cases compared to normal placenta. IHC showed syncytiotrophoblast-specific DIO3 immunostaining in benign CHM cases and normal placenta, while pre-GTN cases of CHM lacked DIO3 expression. We describe two new biomarkers of pre-GTN CHM cases: decreased 14q32 miRNA expression and loss of DIO3 expression by IHC. Differences in imprinting between benign CHM and pre-GTN cases may provide insight into the fundamental development of CHM.
    MeSH term(s) Adolescent ; Adult ; Cohort Studies ; Disease Progression ; Female ; Gene Expression Regulation, Enzymologic/physiology ; Gestational Trophoblastic Disease/enzymology ; Gestational Trophoblastic Disease/genetics ; Gestational Trophoblastic Disease/pathology ; Humans ; Hydatidiform Mole/enzymology ; Hydatidiform Mole/genetics ; Hydatidiform Mole/pathology ; Iodide Peroxidase/biosynthesis ; Iodide Peroxidase/deficiency ; Iodide Peroxidase/genetics ; Pregnancy ; Selenoproteins/biosynthesis ; Selenoproteins/deficiency ; Selenoproteins/genetics ; Young Adult
    Chemical Substances Selenoproteins ; iodothyronine deiodinase type III (EC 1.11.1.-) ; Iodide Peroxidase (EC 1.11.1.8)
    Language English
    Publishing date 2021-06-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2276411-2
    ISSN 1933-7205 ; 1933-7191
    ISSN (online) 1933-7205
    ISSN 1933-7191
    DOI 10.1007/s43032-021-00634-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Fetal-Maternal Hemorrhage in First-Trimester Intrauterine Hematoma.

    Narciso, Thaisa A R M / Hoshida, Mara S / Costa, Priscilla R / Niquirilo, Andrea / Biancolin, Sckarlet E / Lin, Lawrence H / Francisco, Rossana P V / Brizot, Maria L

    Fetal diagnosis and therapy

    2021  Volume 48, Issue 3, Page(s) 227–234

    Abstract: Objective: The objective of this study was to compare the frequency and percentage of fetal hemoglobin (HbF%) by flow cytometry of (1) first-trimester asymptomatic patients with intrauterine hematoma (IUH), (2) first-trimester pregnant patients with ... ...

    Abstract Objective: The objective of this study was to compare the frequency and percentage of fetal hemoglobin (HbF%) by flow cytometry of (1) first-trimester asymptomatic patients with intrauterine hematoma (IUH), (2) first-trimester pregnant patients with vaginal bleeding (VB), and (3) first-trimester asymptomatic pregnant women without hematoma.
    Methods: Prospective study involving pregnant women in the first trimester of pregnancy. Patients with ultrasound findings of asymptomatic hematoma and with VB were paired with asymptomatic pregnant women of same gestational age without hematoma (control group [CG]). Maternal blood HbF% was evaluated by flow cytometry. The groups were compared in terms of circulating fetal hemoglobin and HbF%.
    Results: Sixty-six patients were selected, 22 with hematoma, 17 with bleeding, and 27 in the CG. Fetal hemoglobin was detected in 15 patients with hematoma (68.2%) and 13 with bleeding (76.5%) and in 20 of the control (74.1%) (p = 0.830). The mean HbF% of each group was 0.054, 0.012, and 0.042 for hematoma, bleeding, and control, respectively, and differences were not significant (p = 0.141). There was a moderate negative correlation between the volume of hematoma and HbF% (rSpearman = -0.527; p = 0.012).
    Conclusions: The fetal-maternal hemorrhage expressed by Hbf% in first-trimester pregnancies did not seem to differ between patients with and without ultrasound findings of IUH.
    MeSH term(s) Female ; Hematoma/diagnostic imaging ; Humans ; Pregnancy ; Pregnancy Trimester, First ; Prospective Studies ; Ultrasonography, Prenatal ; Uterine Hemorrhage/diagnostic imaging ; Uterine Hemorrhage/etiology
    Language English
    Publishing date 2021-03-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1066460-9
    ISSN 1421-9964 ; 1015-3837
    ISSN (online) 1421-9964
    ISSN 1015-3837
    DOI 10.1159/000513747
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy.

    Gockley, Allison A / Lin, Lawrence H / Davis, Michelle / Melamed, Alexander / Rizzo, Anthony / Sun, Sue Yazaki / Elias, Kevin / Goldstein, Donald P / Berkowitz, Ross S / Horowitz, Neil S

    Clinics (Sao Paulo, Brazil)

    2021  Volume 76, Page(s) e2830

    Abstract: Objectives: This study aimed to determine the effects of age, race/ethnicity, body mass index, and contraception on human chorionic gonadotropin (hCG) regression following the evacuation of a molar pregnancy.: Methods: This was a retrospective cohort ...

    Abstract Objectives: This study aimed to determine the effects of age, race/ethnicity, body mass index, and contraception on human chorionic gonadotropin (hCG) regression following the evacuation of a molar pregnancy.
    Methods: This was a retrospective cohort study of 277 patients with molar pregnancies between January 1, 1994 and December 31, 2015. The rate of hCG regression was estimated using mixed-effects linear regression models on daily log-transformed serum hCG levels after evacuation.
    Results: There were no differences in hCG half-lives among age (p=0.13) or race/ethnicity (p=0.16) groups. Women with obesity and hormonal contraceptive use demonstrated faster hCG regression than their counterparts (3.2 versus. 3.7 days, p=0.02 and 3.4 versus. 4.0 days, p=0.002, respectively).
    Conclusion: Age and race/ethnicity were not associated with hCG regression rates. Hormonal contraceptive use and obesity were associated with shorter hCG half-lives, but with unlikely clinical significance. It is important to understand whether the clinical characteristics of patients may influence the hCG regression curve, as it has been proposed as a way to predict the risk of gestational trophoblastic neoplasia.
    MeSH term(s) Chorionic Gonadotropin ; Female ; Gestational Trophoblastic Disease ; Humans ; Hydatidiform Mole ; Pregnancy ; Retrospective Studies ; Uterine Neoplasms
    Chemical Substances Chorionic Gonadotropin
    Language English
    Publishing date 2021-08-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2182801-5
    ISSN 1980-5322 ; 1807-5932
    ISSN (online) 1980-5322
    ISSN 1807-5932
    DOI 10.6061/clinics/2021/e2830
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples

    Black, Margaret A / Shen, Guomiao / Feng, Xiaojun / Garcia Beltran, Wilfredo F / Feng, Yang / Vasudevaraja, Varshini / Allison, Douglas / Lin, Lawrence H / Gindin, Tatyana / Astudillo, Michael / Yang, Diane / Murali, Mandakolathur / Iafrate, A. John / Jour, George / Cotzia, Paolo / Snuderl, Matija

    Journal of immunological methods. 2021 Feb., v. 489

    2021  

    Abstract: We validate the use of a lateral flow immunoassay (LFI) intended for rapid screening and qualitative detection of anti-SARS-CoV-2 IgM and IgG in serum, plasma, and whole blood, and compare results with ELISA. We also seek to establish the value of LFI ... ...

    Abstract We validate the use of a lateral flow immunoassay (LFI) intended for rapid screening and qualitative detection of anti-SARS-CoV-2 IgM and IgG in serum, plasma, and whole blood, and compare results with ELISA. We also seek to establish the value of LFI testing on blood obtained from a capillary blood sample.Samples collected by venous blood draw and finger stick were obtained from patients with SARS-CoV-2 detected by RT-qPCR and control patients. Samples were tested with Biolidics 2019-nCoV IgG/IgM Detection Kit lateral flow immunoassay, and antibody calls were compared with ELISA.Biolidics LFI showed clinical sensitivity of 92% with venous blood at 7 days after PCR diagnosis of SARS-CoV-2. Test specificity was 92% for IgM and 100% for IgG. There was no significant difference in detecting IgM and IgG with Biolidics LFI and ELISA at D0 and D7 (p = 1.00), except for detection of IgM at D7 (p = 0.04). Capillary blood of SARS-CoV-2 patients showed 93% sensitivity for antibody detection.Clinical performance of Biolidics 2019-nCoV IgG/IgM Detection Kit is comparable to ELISA and was consistent across sample types. This provides an opportunity for decentralized rapid testing and may allow point-of-care and longitudinal self-testing for the presence of anti-SARS-CoV-2 antibodies.
    Keywords Severe acute respiratory syndrome coronavirus 2 ; antibodies ; blood serum ; point-of-care systems
    Language English
    Dates of publication 2021-02
    Publishing place Elsevier B.V.
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 120142-6
    ISSN 1872-7905 ; 0022-1759
    ISSN (online) 1872-7905
    ISSN 0022-1759
    DOI 10.1016/j.jim.2020.112909
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top